Boehringer Ingelheim

2 articles

Pfizer CEO warns German investment at risk over drug pricing policies

Pfizer is reviewing planned investments in Germany following CEO warnings that government drug price cuts threaten long-term predictability. This mirrors similar investment halts by Eli Lilly and Boeh

reuters · 2026-06-10 04:56

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim invests £150 million over 10 years to launch an AI research center in London aimed at accelerating pharmaceutical drug discovery. This facility serves as the company's fourth glob

reuters · 2026-04-20 05:10